Europe Finance Weekly
SEE OTHER BRANDS

Fresh finance and banking news from Europe

Europe Finance Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Europe Finance Weekly.

Press releases published on May 13, 2025

Affimed Announces Filing for the Opening of Insolvency Proceedings

Affimed Announces Filing for the Opening of Insolvency Proceedings

MANNHEIM, Germany, May 13, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced its decision to file an application for …

Eneba Releases New Survey - Finds Gamers Care More About Price Than Platform

Eneba Releases New Survey - Finds Gamers Care More About Price Than Platform

LONDON, May 13, 2025 (GLOBE NEWSWIRE) -- Digital marketplace Eneba released findings from its 2025 Multi-Platform Gaming Survey, confirming that players are increasingly motivated by price rather than platform or console loyalty. The survey results …

Golar LNG Limited Q1 2025 results presentation – Date change

Golar LNG Limited Q1 2025 results presentation – Date change

Due to a newly scheduled official State visit to the GTA Hub in Mauritania and Senegal, which will be attended by senior management, Golar’s Q1 2025 results will be released before the NASDAQ opens on Tuesday, May 27, 2025. In connection with this the …

PBGH Announces Jumbo Employers’ Top 5 Health Care Priorities

PBGH Announces Jumbo Employers’ Top 5 Health Care Priorities

Oakland, California, May 13, 2025 (GLOBE NEWSWIRE) -- Purchaser Business Group on Health (PBGH), a nonprofit coalition representing 40 private employers and public entities across the U.S., announced today the results of its member survey on top health …

Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Candel Therapeutics Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Announced accepted oral presentation of positive phase 3 randomized placebo controlled clinical trial results of CAN-2409 (aglatimagene besadenovec) in localized prostate cancer at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting …

Lido Merger Sub, Inc. Announces Commencement of Tender Offer and Consent Solicitation for 8.875% Senior Notes due 2029 of Landsea Homes Corporation

Lido Merger Sub, Inc. Announces Commencement of Tender Offer and Consent Solicitation for 8.875% Senior Notes due 2029 of Landsea Homes Corporation

NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Lido Merger Sub, Inc. (the “Company”) announced today that it has commenced a cash tender offer (the “Tender Offer”) to purchase any and all of Landsea Homes Corporation’s (“Landsea Homes”) outstanding 8.875% …

Bitget Launches Starlink Program to Bridge the Digital Divide in Philippine Island Communities

Bitget Launches Starlink Program to Bridge the Digital Divide in Philippine Island Communities

SIARGAO, Philippines, May 13, 2025 (GLOBE NEWSWIRE) -- Bitget, the leading cryptocurrency exchange and Web3 company, has launched its Starlink Program, bringing high-speed satellite internet to remote islands in the Philippines in a bold move to tackle …

Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results

Artelo Biosciences Provides Business Update and Reports First Quarter 2025 Financial Results

SOLANA BEACH, Caif., May 13, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, …

Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results

Quoin Pharmaceuticals Provides Corporate Update and Announces First Quarter 2025 Financial Results

Continued Progress in Ongoing Late-Stage Netherton Syndrome Studies Announced Positive Clinical Data for Adult and Pediatric Netherton Patients Provided Clear Visual Evidence of QRX003 Mechanism of Action Patent Portfolio Expanded to Support Pipeline …

Advanced Technology International Acquires Carrot

Advanced Technology International Acquires Carrot

SUMMERVILLE, S.C., May 13, 2025 (GLOBE NEWSWIRE) -- We are excited to announce that effective March 31, 2025, Advanced Technology International (ATI), a South Carolina based 501(c)3 public service nonprofit, acquired the assets of The Common Pool, LLC, dba …

Auto and Property Insurance Shopping in First Quarter 2025 Elevated Compared to One Year Ago

Auto and Property Insurance Shopping in First Quarter 2025 Elevated Compared to One Year Ago

CHICAGO, May 13, 2025 (GLOBE NEWSWIRE) -- Auto insurance shopping in Q1 2025 increased 10% compared to the same period in 2024. Home insurance shopping was up 5% year over year, according to TransUnion (NYSE: TRU) research. While the trend of elevated …

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates

- Updated BOND-003 clinical results presented at AUA showing best-in-disease durability and tolerability data for Cohort C with 24-month complete response rate of 42.3% by K-M - - Promising early signal in Cohort P with 90.5% high-grade recurrence free …

Abacus Global Management Announces Virtual Livestream Details for the Abacus Investor Day and Longevity Summit on Thursday, June 12th, 2025

Abacus Global Management Announces Virtual Livestream Details for the Abacus Investor Day and Longevity Summit on Thursday, June 12th, 2025

ORLANDO, Fla., May 13, 2025 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leader in the alternative asset management space, today announced details for the virtual livestream of the Abacus Investor Day and …

Remedy Plan Therapeutics Raises $18 Million Financing to Accelerate Advancement of Lead Asset RPT1G into Phase 1/2 Trials

Remedy Plan Therapeutics Raises $18 Million Financing to Accelerate Advancement of Lead Asset RPT1G into Phase 1/2 Trials

Financing includes participation from Schooner Capital, Alexandria Venture Investments, and other existing investors Investment accelerates advancement of RPT1G, a novel NAMPT inhibitor, into a Phase 1/2 trial in patients with acute myeloid leukemia (AML) …

Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments

Monopar Therapeutics Reports First Quarter 2025 Financial Results and Recent Developments

WILMETTE, Illinois, May 13, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical‐stage biopharmaceutical company focused on developing innovative treatments for patients with unmet medical needs, today …

Aemetis Biogas Signs $27 Million Agreement with Centuri to Build Gas Cleanup Systems for 15 Dairy Digesters

Aemetis Biogas Signs $27 Million Agreement with Centuri to Build Gas Cleanup Systems for 15 Dairy Digesters

CUPERTINO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on low and negative carbon intensity renewable fuels, announced today that its Aemetis Biogas subsidiary has …

Pulse Oil Corp. Announces Suspension of Trading

Pulse Oil Corp. Announces Suspension of Trading

VANCOUVER, British Columbia, May 13, 2025 (GLOBE NEWSWIRE) -- Pulse Oil Corp. (“Pulse” or the "Company”) (TSXV: PUL) announces that TSX Venture Exchange (“TSXV”) has suspended trading in Pulse’s common shares due to a cease trade order (“CTO”) issued by …

Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results

Ovid Therapeutics Reports Business Updates and First Quarter 2025 Financial Results

Topline pharmacodynamic biomarker, safety and tolerability results from a Phase 1 study of OV329 are on track to readout in Q3 2025 Ovid’s first program in its KCC2 direct activator library, OV350, has been dosed in a Phase 1 study in Q1 2025; safety and …

VoIP-Pal Affirms Court Acceptance of Second Amended Complaint and Service upon Defendants in Federal Antitrust and RICO Lawsuit

VoIP-Pal Affirms Court Acceptance of Second Amended Complaint and Service upon Defendants in Federal Antitrust and RICO Lawsuit

WACO, Texas, May 13, 2025 (GLOBE NEWSWIRE) -- VoIP-Pal.com Inc. (OTCQB: VPLM) announced that the United States District Court for the District of Columbia has granted its motion for leave to enter its Second Amended Complaint as the operative pleading in …

MeiraGTx Reports First Quarter 2025 Financial and Operational Results

MeiraGTx Reports First Quarter 2025 Financial and Operational Results

-  Announced strategic collaboration with Hologen AI, including a $200 million cash upfront payment to MeiraGTx and the formation of a joint venture, Hologen Neuro AI Ltd, with a further $230 million in capital committed to initially focus on expediting …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service